Health Catalyst IncHCAT
Price$1.70

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
-21.3%projected annual EPS growth
As of 27 Aug 2026
Analyst Coverage
3analysts covering
Consensus: PositiveAs of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Total Revenue Quarterly70.8MTarget: 260000000 to 265000000
Adjusted EBITDA Quarterly9.1MTarget: 30000000 to 33000000
New Bookings AnnuallyTarget: 22000000 to 26000000
Watch Items
  • Divestiture of Vitalware LLC to Med-MetrixTrigger: Transaction closing timeline and regulatory approvals in 2026Action: Monitor the receipt of $147 million in cash and the subsequent full repayment and termination of the $160 million senior secured term loan facility.
  • Project NEXUS Cost SavingsTrigger: Annualized run-rate cost savings of approximately $30 millionAction: Track quarterly reductions in adjusted operating expenses (expected down $3 million to $4 million) and adjusted cost of revenue (expected down $1 million to $2 million) starting in Q2 2026.
Sign in / Sign up to read more

Research as of 20 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.